Depressive Episode With Catatonic Features in a Case of Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS)

Ju Seok Ryu,Sook Joung Lee,In Young Sung,Tae Sung Ko,Han Ik Yoo

DOI: https://doi.org/10.1177/0883073809334380

2009-05-18

Journal of Child Neurology

Abstract:Three months previously, a 17-year-old girl had complained of right-hand side hemiparesis, and her brain magnetic resonance imaging (MRI) showed a signal change in the left temporoparietooccipital area. The 3243A>G mutation was found in mitochondrial DNA. She was diagnosed with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) and was prescribed dichloroacetic acid to treat lactic acidosis. Her health improved. Two months later, she developed drowsiness and generalized weakness. A New lesion was not found on brain MRI, and electrodiagnostic findings were compatible with acute motor sensory axonal neuropathy. Her negative symptoms, such as depressed mood, loss of interest in activities, psychomotor retardation, and hypersomnia, were aggravated. She was prescribed antidepressants and psychostimulants by a psychiatrist after diagnosis of severe depression episode with catatonic features. One month later, her catatonic condition had improved with medication. Our experience shows that psychiatric diagnostic evaluation of abruptly regressed neurologic and clinical features is important, even in a patient with devastating underlying disease.

pediatrics,clinical neurology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the situation of severe depressive episodes with catatonic features in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke - like episodes (MELAS). Specifically, the author described the first case of severe depressive episodes with catatonic features related to MELAS, and explored the manifestation of this symptom in MELAS patients and its treatment effect.

MELAS is a multisystem disease caused by mitochondrial DNA mutations, most commonly the 3243A>G mutation, which can lead to progressive encephalopathy and stroke - like episodes, and may ultimately result in disability and early death. The case in the paper showed that in addition to the symptoms of MELAS, this 17 - year - old female patient also had severe depressive symptoms, including low mood, loss of interest in activities, psychomotor retardation, and excessive sleepiness. These symptoms were improved after the administration of antidepressant drugs (such as escitalopram) and psychostimulant drugs (such as methylphenidate).

Through this case, the author emphasized the importance of psychiatric diagnostic evaluation in patients with severe underlying diseases such as MELAS, even when the patient shows suddenly deteriorated neurological and clinical features. This indicates that even in the context of a devastating underlying disease, correct diagnosis and timely treatment can still significantly improve the patient's condition.